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SUMMARY
The postnatal period is critical for brain and behavioral development and is sen-
sitive to environmental stimuli, such as nutrition. Prevention of weaning from
maternal milk was previously shown to cause depressive-like behavior in rats.
Additionally, loss of dietary casein was found to act as a developmental trigger
for a population of brain opioid receptors. Here, we explore the effect of expo-
sure to milk containing A1 and A2 b-casein beyond weaning. A1 but not A2
b-casein milk significantly increased stress-induced immobility in rats, concomi-
tant with an increased abundance of Clostridium histolyticum bacterial group in
the caecum and colon of A1 b-casein fed animals, brain region-specific alterations
of m-opioid and oxytocin receptors, and modifications in urinary biochemical pro-
files. Moreover, urinary gut microbial metabolites strongly correlated with
altered brain metabolites. These findings suggest that consumption of milk con-
taining A1 b-casein beyondweaning agemay affect mood via a possible gut-brain
axis mechanism.
INTRODUCTION
During the first 2 years of life, the human brain undergoes a period of rapid growth and development, which
is sensitive to both genetic and environmental stimuli (Chen and Baram, 2016). Nutrition has an influential
role in this process with evidence suggesting variations in dietary exposures during this developmental
window can contribute to changes in brain structure and function with consequences for mental health dis-
orders (Bolton and Bilbo, 2014; Borre et al., 2014). Milk is the primary source of nutrients in mammals during
early life and the removal of milk and introduction of a solid diet, i.e. the weaning process, represents a
major nutritional event during infancy. While weaning practices vary among the human population, with
differences in age of weaning and type of milk consumed, the influence of such variables on brain devel-
opment, structure, function, and behavior remains poorly understood.
Mammalian milk components have been shown to interact with and modify opioidergic systems in neo-
nates (Brantl et al., 1979; Kitchen et al., 1995; Teschemacher et al., 1997). We have previously demonstrated
in rats that weaning on postnatal day (PND) 21, the standard age of weaning in rodents (Cramer et al., 1990),
acts as a signal for the developmental activation of a population of opioid receptor subtype (Kitchen et al.,
1995). This effect was shown to be independent of psychological (maternal deprivation) or physiological
(suckling) stimuli and is solely dependent on the loss of dietary casein (Goody and Kitchen, 2001). As the
opioid system is known to play a crucial role in the regulation of emotional behavior (Lutz and Kieffer,
2013; Puryear et al., 2020), it was hypothesized that the weaning process may impact on such behavior.
To this end, we have also demonstrated that preventing the weaning process for 5 days in rats resulted
in increased stress-induced immobility during the forced swim test (FST), concomitant with a resistance
to stress-induced modulation of oxytocin receptors (OTrs) in amygdala nuclei, indicative of passive
stress-coping mechanisms (Farshim et al., 2016).
Emerging evidence suggests that the resident bacteria of the gastrointestinal tract (GI), collectively known
as the gut microbiota, play a key role in the development of host’s brain and behavior through amechanism
known as the gut-brain axis (Cryan et al., 2019). These gut bacteria and their resultant metabolome sit at the
interface of environmental dietary exposure and brain development. We therefore investigated the impact
1Department of Psychiatry,
Icahn School of Medicine at
Mount Sinai, New York, NY
10029, USA
2Seaver Autism Center for
Research and Treatment,
Icahn School of Medicine at




Faculty of Medicine, Imperial



















8School of Biosciences and
Medicine, Faculty of Health
and Medical Sciences,
University of Surrey,

















iScience 24, 103048, September 24, 2021 ª 2021 The Authors.




of weaning on gut bacterial, host, and integrated pan-kingdom metabolism. Indeed, restricting the wean-
ing process was also found to alter the compositional structure of the intestinal microbiota and its meta-
bolic exchange with the host (Farshim et al., 2016). Although the mechanism underlying these effects re-
mains unclear, these findings suggest weaning may affect the maturation of the central nervous system
by modulating the developing gut-brain axis.
Casein is one of the most abundant proteins found in milk, and it has been extensively studied for its ability to
release peptide fragmentswith opioid activity uponproteolytic cleavage (Kaminski et al., 2007). Themost widely
studied group of these peptides is the b-casomorphins, which derive from milk b-casein and have been iden-
tified in bovine, ovine, and human milk (Teschemacher et al., 1997). b-Casein makes up 30% of the total protein
content in bovine milk, and it is mainly present in two major genetic variants: A1 and A2 (Kaminski et al., 2007).
These two variants differ in the presence of either histidine (His67) in A1 b-casein or proline (Pro67) in A2 b-casein
at position 67 of this protein. The emergence of the A1 variant was consequential to a point mutation in ances-
tors tomodern European-type cattle. As a consequence, commercially availablemilk inmanyWestern countries
contains a mixture of A1 and A2 b-casein (Pal et al., 2015). The proteolytic cleavage of A1 but not A2 b-casein
during digestion by host and gut microbial enzymes results in the release of b-casomorphin-7 (BCM-7), a bioac-
tive peptide (Jinsmaa and Yoshikawa, 1999) with a high affinity for m-opioid receptors (MOPrs), which are not
only expressed in the brain but also along the GI tract and various immune cells (Brantl et al., 1981; Tesche-
macher, 2005; Nam et al., 2019). Moreover, BCM-7 has been implicated in the pathophysiology of a wide range
of disorders, including abnormal gastrointestinal function (Zoghbi et al., 2006), inflammation (Yadav et al., 2020),
and mental health disorders such as schizophrenia and autism spectrum disorders (Reichelt et al., 1981;
Jarmołowska et al., 2019).
Given the evidence of a potential role for milk casein to impact brain development and behavior, here we
investigate the exposure to casein-rich milk containing both A1 and A2 b-casein variants and casein-free
milk beyond the standard weaning age in rats and its influence on behavior, neurochemical, microbial,
and metabolic profiles. To further elucidate the influence of these casein variants, the effect of milk con-
sumption containing both A1 and A2 b-casein or exclusively A2 b-casein beyond weaning was also
investigated.
RESULTS
Consumption of milk containing casein beyond weaning age results in increased
stress-induced immobility during the FST
To assess the role of milk casein in driving the phenotypic, biochemical, and microbial variation associated
with delayed weaning, an animal study was performed with three groups of eight male, Wistar albino rats.
These animals had free access to water, rat chow diet, and were housed with their cross-fostered mothers
until PND21, at which point mothers were removed from the cage, effectively weaning the pups (Figure 1A).
The control group was maintained on standard drinking water from PND21 to PND25. The casein-rich
group was provided with a milk formula containing 20% (w/w) fresh weight casein (4.24% w/v casein
when in liquid form), reflective of slightly higher casein levels than normally found in bovine milk (Roy
et al., 2020) and thus defined as casein-rich milk (see Table S2 for milk nutritional information). The third
group was provided with milk lacking casein, with total protein levels maintained using soya as a replace-
ment protein, hence named casein-free milk (see Table S2 for milk nutritional information). Of note, casein
was exclusively present in the milk source. The casein-rich group was observed to collectively consume a
greater amount of milk compared to casein-free counterparts (Figure S1A) but did not gain significantly
more weight compared to other groups (Figure S1B). During the FST, the total amount of time the rat spent
still, not attempting to escape from the water, was measured and reported as total immobility time. Under
normal physiological conditions, animals display escape-like behaviors during the FST, and antidepres-
sants are known to increase this measure in rats (Detke et al., 1995; Lino-De-Oliveira et al., 2005). Animals
fed casein-rich milk displayed significantly increased immobility time compared to both control (p < 0.01;
analysis of variance [ANOVA] followed by Tukey’s HSD post-hoc test) and casein-free groups (p < 0.05),
indicative of a depressive-like phenotype (Figure 1B).
To confirm that the observed depressive-like phenotype derived from the consumption of higher levels of
milk casein, we conducted a dose response study with different concentrations of milk casein, using an
identical protocol to the aforementioned study. Specifically, identical casein-free formula utilized in the
previous study (Special Diet Services, Cambridge, UK) was spiked with 10% or 20% w/w casein (Sigma,
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Figure 1. Milk casein consumption beyond weaning age results in increased stress-induced immobility, indicative of depressive-like behavior,
alterations in brain m-opioid (MOPr) and oxytocin receptors (OTr), gut microbial composition, and urine biochemical profiles
(A) Study design. Rats were received at the experimental animal facility on PND7 and weaned on PND21. Divided in three groups, two received either casein-
free or casein-rich milk while the control group received only water from PND21 to PND26. The FST was conducted on PND25 (pre-test) and PND26 (test).
Urines were collected for 24 hr on PND27, before sacrifice, for 1H NMR spectroscopy analysis. The brain and gut were dissected to collect samples for
receptor autoradiography and FISH analysis, respectively.
(B) FST revealed significantly increased immobility time in the casein-rich group, indicative of depressive-like behavior, compared to both control (p = 0.004)
and casein-free group (p = 0.016) (ANOVA followed by Tukey’s HSD post-hoc test).
(C and D) m-opioid (MOPr) and oxytocin receptors (OTr) autoradiography of different brain regions. Animals from the casein-rich group showed decreased
MOPr with respect to control in the somatosensory cortex (S1/S2 Deep), hypothalamus, amygdala, nucleus accumbens (AcbC) whole and shell. Additionally,
these animals presented significantly less OTr compared to control in BLA, basal medial amygdala (BMA), hippocampus, thalamus, and central nucleus of
amygdala (CE) (ANOVA followed by Tukey’s HSD post-hoc test).
(E and F) Computer-enhanced representative autoradiograms of adjacent coronal brain sections at the level of thalamus (bregma 2.80 mm). m-opioid
receptors (MOPrs) labeled with [3H]-DAMGO (4nM) showed decreased receptor binding in the deep layer of the somatosensory cortex of the casein-rich
animals compared to control and casein-free. Oxytocin receptors (OTrs) labeled with [125I]-OVTA (50 pm) showed decreased receptor binding in the BLA
casein-rich animals compared to control and casein-free. The color bar illustrates a pseudo-color interpretation of black and white film images in fmol/mg
tissue equivalent.
(G and H) FISH analysis revealed no differences in total bacteria abundance in any of the analyzed gut regions between casein-rich and casein-free animals.
Nevertheless, the casein-rich group presented higher abundance of the Clostridium histolyticum group after FST in the caecum and colon compared to the
casein-free group (Wilcoxon test followed by Benjamini-Hochberg correction).
(I–K) Pairwise PLS-DA of urine biochemical profiles and loadings of metabolites with VIP>1. Urine of control animals were characterized by a higher presence
of sarcosine, dimethylglycine, methylnicotinamide, trigonelline, and citrate compared to both the other groups. Rats fed with casein-rich milk excretedmore
putrescine and hippurate compared to the other groups while rats fed with casein-free milk excreted more glycine, benzoate, and alanine. Boxplots
show first (lower) quartile, median, and third (upper) quartile. Significant and close to significant p values are represented as ,p < 0.1, *p < 0.05, **p < 0.01,
***p < 0.001. Abbreviations: S1/S2, somatosensory cortex; AcbC, nucleus accumbens; Amy, amygdala; CPu, caudate putamen; BLA, basal lateral amygdala;
BMA, basal medial amygdala; CE, central nucleus of amygdala.
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Poole, UK) in milk powder. A control group provided with un-spiked casein-free milk was also included.
During the FST, a clear concentration-dependent relationship between milk casein and immobility
behavior was observed, with the 20% w/w group but not the 10% w/w group displaying an increased immo-
bility time compared to control (Figure S2A). This is consistent with the casein-rich vs casein-free observa-
tions. Both 10% and 20% w/w groups gained significantly more weight and consumed more milk overall
compared to the control group (Figures S2B and S2C), also consistent with the observed trends in the pre-
vious study.
Casein consumption modulates opioid and oxytocin receptor systems in specific brain
regions
To assess if milk casein exposure beyond weaning age alters brain neurochemistry, potentially contributing
to the behavioral changes observed in the FST, quantitative autoradiographic binding of MOPrs and OTrs
was performed. These receptors were selected as they are sensitive to alterations induced by weaning and
due to their involvement in emotional regulation (Lutz and Kieffer, 2013; Zanos et al., 2014). MOPr binding
was carried out using [3H]-DAMGO on coronal sections cut across the whole brain. Reduced MOPr binding
in the deep layer of somatosensory cortex was observed in casein-rich group compared to the casein-free
counterpart (p < 0.05; ANOVA followed by Tukey’s HSD post-hoc test) (Figures 1C and 1E). Casein was also
found to decrease MOPr binding in the hypothalamus (p < 0.05) and amygdala (p < 0.05) compared to con-
trol animals. Both casein-rich and casein-free milk caused a decrease in MOPr binding in the whole nucleus
accumbens (p < 0.01 and p < 0.05, respectively) and its shell (p < 0.01 and p < 0.05 respectively), indicating a
general milk effect, independent of casein, on MOPr binding in these regions. Meanwhile, casein-free milk
was found to reduceMOPr binding in the caudate putamen (CPu) compared to both control (p < 0.001) and
casein-rich group (p < 0.05) (Figure 1C). The effect of casein-rich or casein-free treatment was not found to
be significant in the rest of the regions analyzed (Figure S3A). OTr autoradiographic binding was carried
out using [125]-OVTA on coronal rat brain sections. Reduced OTr binding in the basal lateral amygdala
(BLA) was observed in casein-rich treated animals compared to both control and casein-free counterparts
(p < 0.05) (Figures 1D and 1F). Casein-rich milk also caused a significant reduction in OTr binding in the
basal medial amygdala (BMA) (p < 0.05) and hippocampus (p < 0.001) compared to control (Figure 1C).
The effects of casein-rich or casein-free treatments were not found to be significant in any of the other re-
gions analyzed (Figure S3B).
C. histolyticum group abundance in the caecum and colon increases following casein
exposure and FST
Luminal contents from five different regions of the GI of the casein-rich and casein-free animals were
collected on PND27, after FST, and analyzed with fluorescence in situ hybridization (FISH) to quantitatively
assess the presence of specific gut bacteria in the samples. Casein intake was not found to alter the total
count of bacteria in any of the analyzed regions (Figure 1G). Nevertheless, bacteria in the Clostridium clus-
ter I and II (Clostridium histolyticum group) were significantly increased in the caecum and colon (p < 0.05
and p < 0.01, respectively; Wilcoxon test followed by Benjamini-Hochberg correction) of animals fed
casein-rich milk compared to the casein-free group (Figure 1F). No significant differences were observed
in the abundance of other early life-related gut bacteria, such as Bifidobacterium spp. and Lactobacillus/
Enterococcus spp., between the two treatments in any of the examined regions (Figure S4).
Casein-rich and casein-free milk modulate urinary metabolic profiles
The metabolic profiles of urine collected from control, casein-rich, and casein-free treated animals on
PND27 were analyzed using 1H NMR spectroscopy. Pairwise supervised analysis using partial least
squares-discriminant analysis (PLS-DA) confirmed statistical differences between the casein-rich, casein-
free, and control groups. Compared to control, casein-rich milk intake resulted in an increase in the urinary
excretion of hippurate, creatinine, allantoin, dimethyl sulfone, and putrescine and a decrease in the excre-
tion ofN-methylnicotinamide (NMND), trigonelline, dimethylglycine (DMG), citrate, and sarcosine (PLS-DA
Q2Y = 0.77) (Figure 1I). Casein-free milk consumption resulted in a higher excretion of benzoate, glycine,
dimethyl sulfone, and alanine and a reduced excretion of NMND, trigonelline, betaine, DMG, sarcosine,
2-oxoglutarate, malate, and citrate compared to control (PLS-DA Q2Y = 0.85) (Figure 1J). Finally, metabo-
lites driving the separation between casein-rich and casein-free animals were hippurate, putrescine,
maltose, malate, and betaine, both higher in animals fed casein-rich milk, and benzoate, glycine, acetate,
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Specific urinary metabolites were associated with increased immobility time. Ametabolic network was con-
structed using the Spearman correlation between immobility time and the metabolites. Immobility posi-
tively correlated with some microbial and endogenous metabolites such as hippurate (r = 0.55), allantoin
(r = 0.56), and creatinine (r = 0.56) while it negatively correlated with alanine (r = 0.56). Sarcosine and
acetate were negatively associated with immobility time via a number of known and unknown metabolites
(Figure 2).
Consumption of commercialized milk (A1/A2 b-casein) beyond weaning results in increased
stress-induced immobility in the FST
To investigate if the A1 and A2 b-casein variants are inducing different behavioral phenotypes and meta-
bolic changes, as observed in the casein-rich vs casein-free study, we compared the consumption of
commercialized bovine milk containing either a combination of A1 and A2 b-casein or exclusively A2
b-casein from PND21 to PND25 (Figure 3A). Consumption of commercial milk containing A1/A2 b-casein
resulted in an increase in immobility time compared to the control group during the FST (p < 0.01;
ANOVA followed by Tukey’s HSD post-hoc test) (Figure 3B). No significant difference in immobility time
was observed between animals receiving A2 milk and control or commercial milk containing A1/A2
b-casein. Milk consumption per cage was comparable between groups, and no significant differences in
weight gain were observed (Figure S5). Additionally, locomotor behavior assessed one hour before the
FST on PND25 revealed no significant differences in motor activity between groups (Figure S6).
Commercialized milk (A1/A2 b-casein) modulates MOPr and brain metabolic profiles
Quantitative autoradiographic binding of MOPr using [3H]-DAMGO was carried out on coronal sections
across the whole brains of the animals. Commercial milk containing A1/A2 b-casein was found to induce
higher levels of MOPr across several of brain regions. A significant increase in MOPr density was detected
in themotor and somatosensory cortex, both superficial and deep, of rats exposed to commercial milk con-
taining A1/A2 b-casein compared to control (p < 0.05; ANOVA followed by Tukey’s HSD post-hoc test) (Fig-
ures 3C and 3D). Notably, A2 b-casein milk exposure did not cause any significant changes in MOPr binding
in these regions compared to control or commercial milk containing A1 b-casein. No significant differences
were observed in any of the other analyzed regions (Figure S7).
To explore the potential role of these casein variants in modulating the neurobiochemical profiles of the
animals, the frontal cortices collected on PND27 were analyzed using 1H NMR spectroscopy. PLS-DA
Figure 2. Correlation network between immobility and urine metabolites
Immobility was positively correlated to creatinine, allantoin, and hippurate and negatively correlated to alanine.
Significant Spearman correlations after Benjamini-Hochberg correction were plotted (p < 0.05). Red indicates positive
correlation and blue negative correlation. Thicknesses of the edges are weighted on correlation intensity.
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Figure 3. A1/A2 milk consumption beyond weaning age results in increased stress-induced immobility, indicative of depressive-like behavior,
alterations in brain m-opioid receptors (MOPr), and brain and urine biochemical profiles
(A) Study design. Rats received at the experimental facility on PND7 and weaned on PND21. Divided in three groups, two received either A1/A2 milk or A2
milk while control group received only water from PND21 to PND26. The FST was carried out on PND25 (pre-test) and PND26 (test). Urines were collected for
24 hr on PND27, before sacrifice, in order to analyze them with 1H NMR spectroscopy. Brains were dissected, and the frontal cortex was analyzed with
1H NMR spectroscopy. Brains from different animal cohort were collected for receptor autoradiographic analysis.
(B) Rats in the A1/A2 milk group, but not the A2 milk group, exhibited significantly increased immobility time in the FST compared to control (p = 0.009)
(ANOVA followed by Tukey’s HSD post-hoc test).
(C) Autoradiography of m-opioid receptors (MOPr) in different brain regions. Animals fed A1/A2 milk showed significantly increased MOPr with respect to
control in the motor cortex (M1/M2 Sup and M1/M2 Deep), somatosensory cortex (S1/S2 Sup and S1/S2 Deep), and hippocampus (ANOVA followed by
Tukey’s HSD post-hoc test).
(D) Computer-enhanced representative autoradiograms of adjacent coronal brain sections at the level of the thalamus (bregma 2.80 mm). m-opioid
receptors (MOPrs) labeled with [3H]-DAMGO (4nM) showed increased receptor binding across multiple brain regions in A1/A2 milk-treated animals
compared to controls and A2 animals in some regions, including the deep layer of the motor cortex and hippocampus. The color bar illustrates a
pseudocolor interpretation of black and white film images in fmol/mg tissue equivalent.
(E–G) Pairwise PLS-DA of urine biochemical profiles and loadings of metabolites with VIP>1. Urine of control animals was characterized by a higher presence
of methylamine, citrate, 2-oxoglutarate, fumarate, and 3-indoxysulfate compared to both the other two groups. Rats fed with A1/A2 milk excreted more
methylnicotinamide compared to the other groups while rats fed with A2 milk acetate, sarcosine, and trimethylamine.
(H–I) Pairwise PLS-DA of frontal cortex metabolic profiles and loadings of metabolites with VIP>1. Brain biochemical profiles of control and A2 milk animals
were not significantly different. Rats fed with A1/A2 milk presented more acetylcholine, phosphocholine, and IMP in their frontal cortex compared to the
other groups while the other presented more formate, adenosylhomocysteine, guanosine, ethanolamine, 3-hydroxyisovalarate, glycerol, choline,
fumarate, and glutamine. Boxplots show first (lower) quartile, median, and third (upper) quartile. Significant and close to significant p values are represented
as ,p < 0.1, *p < 0.05, **p < 0.01, ***p < 0.001. Abbreviations: S1/S2 somatosensory cortex; M1/M2, motor cortex.
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models showed a clear separation of the A1/A2 milk group from the other two groups and also revealed
that the biochemical profiles of A2 milk group and control were not significantly different, mirroring the
MOPr binding results. Compared to both control (PLS-DA Q2Y = 0.38) and the A2 milk group (PLS-DA
Q2Y = 0.64), the frontal cortices of animals fed with the commercial milk containing A1 b-casein contained
a higher amount of phosphocholine, acetylcholine, IMP, and carnitine phosphate and a lower amount of
3-hydroxybutyrate, ethanolamine, choline, fumarate, guanosine, formate, glutamine, glycerol, 3-hydroxi-
sovalarate, and adenosylhomocysteine (Figures 3H and 3I).
Commercialized milk (A1/A2 b-casein) and A2 milk modulate urinary metabolic profiles
Urine of animals fed A1/A2 milk, A2 milk, or water were collected on PND27 and analyzed with 1H NMR
spectroscopy. Pairwise PLS-DAmodels were generated to identify which metabolites were driving the sep-
aration between the groups. Urine of commercial milk containing A1/A2 b-casein group presented higher
concentrations of creatinine, allantoin, succinate, and NMND and decreased abundance of acetate, trime-
thylamine (TMA), benzoate, glycine, trigonelline, maltose, lactose, dimethyl sulfone, and sarcosine
compared to animals who received A2 milk (PLS-DA Q2Y = 0.61) (Figure 3E). Compared to control, com-
mercial milk containing A1/A2 b-casein fed animal urine presented more galactitol, NMND, taurine, and
putrescine but less methylamine, dimethyl sulfone, benzoate, glycine, citrate, 2-oxoglutarate, fumarate,
malate, and 3-indoxysulfate (PLS-DA Q2Y = 0.73) (Figure 3F). Finally, the A2 milk group secreted more pro-
pionate, DMG, sarcosine, TMA, taurine, formate, galactitol, and acetate and less 2-oxoglutarate, citrate,
methylamine, 3-indoxysulfate, and fumarate compared to the control group (PLS-DA Q2Y = 0.76)
(Figure 3G).
Urinary microbial metabolites correlate with brain metabolites
DIABLO (Data Integration Analysis for Biomarker discovery using Latent variable approaches for Omics
studies (Singh et al., 2019)) was used to integrate the urinary and brain metabolic profiles from control,
commercial milk containing A1/A2 b-casein, and A2 b-casein milk groups and elucidate possible connec-
tions between endogenous and microbial metabolites in the urine and frontal cortex metabolism. A strong
positive correlation (r > 0.7) was identified between acetate and trimethylamine, urinary metabolites
derived from gut microbial activity, and formate, adenosylhomocysteine, ethanolamine, and guanosine
present in the brain. These microbial products also negatively correlated with acetylcholine, phosphocho-
line, oxypurinol, and inosine monophosphate (IMP) in the frontal cortex. Urinary succinate, an endogenous
host and microbial metabolite, was also found to be positively correlated with IMP, acetylcholine, phos-
phocholine, and oxypurinol and negatively correlated with ethanolamine, formate, and adenosylhomocys-
teine in the frontal cortex (Figure 4).
DISCUSSION
Here, we interrogated the impact of postweaning exposure to the casein component of milk and its two
major variants A1 and A2 b-casein on behavioral, neurochemical, gut microbial, and metabolic endpoints.
We demonstrate that postweaning exposure to casein-rich milk content (containing both A1 and A2
b-casein variants) or commercial milk, containing both A1 and A2 b-casein variants, enhances stress-
induced immobility behavior during the FST, indicative of a depressive-like behavioral phenotype, and in-
duces distinct neurochemical changes in receptor density and metabolomic profile. Neither casein-free
milk nor that containing exclusively the A2 b-casein variant was able to induce such marked effects. This
indicates that the A1 b-casein component of milk drives these observations.
In accordance with a previous study (Silva et al., 2015), a clear preference toward casein-rich milk compared
to casein-free soy protein-based milk was detected with rats consuming more than double the amount of
casein-rich milk compared to casein-free milk. As such, it is unclear if protein quantity rather than type
(casein vs soy) may be the underlying cause of the observed immobility behavior. However, the lack of sig-
nificant weight gain in the casein-rich group compared to casein-free and control groups, despite the
increased milk consumption, suggests that rats are likely to have adapted their solid food and energy
intake based on their protein need, which is a well-characterized behavior (Bensaı̈d et al., 2003). Several
studies show that the amino acid composition of consumed protein, hence protein quality, can influence
brain neurochemistry and behavior (Lasley and Thurmond, 1985; Chamberlain et al., 1987; Markus et al.,
2000). Furthermore, ingestion of a soy protein diet in mice, before transitioning to a short photoperiod
condition, was shown to result in lower immobility in the FST compared with mice provided a casein
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diet (Otsuka et al., 2015), further highlighting the impact of protein quality on FST immobility behavior. It is
likely that the observed behavioral phenotype is the result of a combination of differences in the quantity
and quality of protein, in this case casein. This is supported by our findings from the casein-spikedmilk con-
centration response study. Here, a significant effect on immobility in the FST was observed only at a high
casein dose of 20% w/w.
A significant decrease of MOPr binding was detected in the deep layer of the somatosensory cortex of rats
with prolonged exposure to casein-rich milk compared to casein-free and control groups. This outcome
may be mediated by peptide products derived by the proteolytic breakdown of casein, although this
cannot be fully elucidated from this study. Milk caseins are a known source of exogenous opioid peptides,
generated in the GI during digestion. These peptides can cross both the intestinal and the blood brain bar-
riers to interact with opioid receptors in the brain (Zioudrou et al., 1979). The opioid activity found in
mammalian milk is largely attributed to the presence of b-casein-derived BCM-5 and BCM-7, as well as
a-casein-derived f90-96 and f90-95, which are all MOPr agonists (Brantl et al., 1981). Whether region-spe-
cific deficit in MOPr contributes to the generation of the observed behavioral phenotype cannot be ascer-
tained from the current study but given the key role that MOPr plays in the modulation of mood (Lutz and
Kieffer, 2013; Peciña et al., 2019) and the role of somatosensory cortex in emotional processing (Kang, 2018;
Kropf et al., 2019), it is likely to be implicated. Changes to MOPr density were also observed in the nucleus
accumbens of animals receiving both the casein-rich and casein-free milk compared to control animals,
while casein-free milk alone decreased MOPr in the CPu, suggesting casein independent effects of milk
on MOPr density. Soy protein, used to replace the casein component in the casein-free milk, was shown
to release soymorphins, such as soymorphin-5, which are also specific ligands for MOPr (Ohinata et al.,
2007). Hence, enhanced soymorphin generation in rats exposed to casein-free milk may explain the alter-
ations observed in the CPu compared to control treated rats. Other mechanisms may also contribute to
these observations. For example, Duraffourd et al. demonstrated that products from a high-protein diet
can antagonize intestinal MOPs to activate a gut-brain neural pathway to induce satiety, indicating an
Figure 4. Integration of urine and frontal cortex biochemical profiles showed correlation between urinary
microbial metabolites and several brain metabolites
Projection of the latent structures with DIABLO showed separation of the different groups and high positive or negative
correlation (r > 0.7) between several urine and brain metabolites on the first component. Urinary acetate and
trimethylamine positively correlated with formate, adenosylhomocysteine, ethanolamine, and guanosine and also
negatively correlated with acetylcholine, phosphocholine, oxypurinol, and IMP in the brain. Urinary succinate was
positively correlated with IMP, acetylcholine, phosphocholine, and oxypurinol and negatively correlated with
ethanolamine, formate, and adenosylhomocysteine in the brain.
ll
OPEN ACCESS
8 iScience 24, 103048, September 24, 2021
iScience
Article
antagonistic effect of protein quantity, irrespective of quality, on MOPr (Duraffourd et al., 2012). Besides
the stimulatory effect of protein on satiety mechanism (Fromentin et al., 2012), there is evidence to suggest
that a high protein diet can also modulate the brain reward system via poorly defined mechanisms (Journel
et al., 2012).
OTr binding levels were downregulated in the basal lateral amygdala of animal fed casein-rich milk
compared to both control and casein-free groups, indicating a casein-induced effect on OTr density.
The role of the endogenous central oxytocinergic system as a regulator of stress-related behaviors and
emotionality has been well established (Gigliucci et al., 2014; Zanos et al., 2014). Accumulating evidence
suggests that oxytocin released in the amygdala, a key brain region involved in emotional processing
(LeDoux, 2009), in response to stress, is responsible for the generation of passive stress-coping strategies
(Yan et al., 2014). Dysregulation of the oxytocinergic system in the amygdala has been implicated in several
stress-related neuropsychopathologies (Parker et al., 2010). For instance, low amygdala OTr levels have
been consistently associated with increased anxiety (Yoshida et al., 2009). As a result, the effect of milk
casein on the amygdala oxytocinergic system may contribute to the mechanism underlining the stress-
induced immobility phenotype detected following casein milk exposure. No effect on OTr levels was
observed in our previous study (Farshim et al., 2016), suggesting a more marked effect of casein on OTr
density when delivered in a milk formula compared to prolonged breastfeeding. To our knowledge, this
is the first study to demonstrate a marked and direct link between nutritional exposures in early life and
the development of the brain OTr system, which may have lifelong implications in the regulation of stress
reactivity (Bales and Perkeybile, 2012).
From urinary metabolic profiles, differences in the excretion of metabolites related to gut microbial activity
were observed between rats receiving either casein-rich or casein-free milk. Animals consuming casein-rich
milk excreted greater amounts of hippurate, a microbial-mammalian co-metabolite arising from the bac-
terial breakdown of plant phenols to produce benzoate, which is subsequently conjugated with glycine
in the liver to produce hippurate (Temellini et al., 1993). This metabolite was significantly correlated with
increased animal immobility time in our study. Variation in hippurate excretion may indicate an increase
in the activity of certain bacterial species with casein intake, increasing the production of benzoate and
depleting the availability of glycine, an excitatory amino acid found to be lower in the plasma of patients
with major depression (Altamura et al., 1995). Consistently, the casein-rich group excreted lower amounts
of glycine compared to control animals, as well as lower amounts of dimethylglycine and sarcosine (methyl-
glycine). Such changes may reflect compensatory strategies to increase glycine availability. Interestingly,
lower amounts of dimethylglycine have been documented in patients with depression (Zheng et al.,
2013), and sarcosine intake has been shown to improve depressive-like behavior (Chen et al., 2017).
A significant increase in the abundance of bacteria in theC. histolyticum group was noted in the cecum and
colon of rats consuming casein-rich milk compared to those fed casein-free milk, following the FST. Inter-
estingly, hippurate excretion has previously been linked to increased abundances of the Clostridium genus
in the gut (Pallister et al., 2017). Differences in protein quantity and quality, in combination with stress, may
underlie these observations and modify the production of metabolites from the host genome and micro-
biome. As with behavior and neurochemistry, gut microbial composition and their respective metabolic
products are known to be influenced by protein quantity and quality (Zhao et al., 2018). For example,
greater amounts of undigested protein have been shown to lead to an increase of pathogenic microorgan-
isms associated with a higher risk of metabolic diseases (Zhao et al., 2018). Moreover, the abundance of
Akkermansia and Bifidobacterium has been shown to increase in mice supplemented with branched-chain
amino acids (Yang et al., 2016). These findings and the observation that different amino acids affect host
and bacterial metabolism differently (Madsen et al., 2017) suggest that the microbial and metabolic differ-
ences reported here are driven by differences in protein quality (i.e. amino acid composition of casein vs
soy), albeit at higher levels in the casein-rich group.
Despite the two milk diets being carefully nutritionally matched, there were subtle differences in the
compositional breakdown of the macronutrients. For example, the fat source of casein-rich milk came
from vegetables and fat mix, whereas for casein-free milk, it came from maize and soy oil, indicating differ-
ences in the concentrations of saturated and monounsaturated and polyunsaturated fatty acids in the two
milks. Given that the casein-rich group consumed significantly more milk than the casein-free group, it is
likely that these rats consumed higher amount of fats. However, no significant differences were noted in
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weight gain between the study groups, suggesting that this difference in nutrient intake had a minimal ef-
fect on metabolism and body weight. A study investigating the effects of different dietary oils on FST
behavior failed to find any significant differences in immobility behavior between the different groups
(Kato, 2015), suggesting that quality of fat may not influence immobility behavior. It is plausible that differ-
ences in quantity and quality of fat consumedmay have an impact on MOPr and OTR density in the brain. A
recent study by Deol et al. demonstrated a profound dysregulation of hypothalamic gene expression in
mice fed soy oil-containing diet compared to control and coconut oil-containing diet with different propor-
tions of fatty acid composition (Deol et al., 2020). An increase in oxytocin expression and a decrease of
oxytocin immunoreactivity were detected in the hypothalamus of mice fed diet containing soybean oil
compared to mice fed control or coconut oil-containing diet, clearly demonstrating that quality of fat con-
sumption impacts on brain neurochemistry. Although in the current study, no effect of milk (either casein
rich or casein free) was detected on OTR density in the hypothalamus and OTR density was not influenced
by soya oil-containing casein-free diet, the possibility that changes in neurochemistry may be influenced by
consumption of fats of different fatty acid composition warrants future investigation.
Consistent with casein-rich milk, exposure to commercial milk containing A1/A2 b-casein for 5 days after
weaning was also found to result in increased stress-induced immobility behavior during the FST, sugges-
tive of a depressive-like phenotype. Such observations were not seen in animals fed bovine A2 b-casein
milk postweaning or control animals, suggesting that the bioactive compound arising from the breakdown
of A1 b-casein, BCM-7, may be at least partly responsible for this behavioral phenotype. Unlike the casein-
rich milk fed group, rats consumed the same amount of commercial bovine A1/A2 b-casein (A1/A2 group)
and A2 b-casein (A2 group) containing milks. Given that the macronutrient composition of the two bovine
milks were closely matched with only the b-casein variant differing, it is highly unlikely that any behavioral,
neurochemical, and metabolic differences observed following consumption of the two milks is caused by
differences in quantity or quality of macronutrients (e.g. fats, proteins). Intriguingly, exposure to commer-
cial milk containing A1/A2 b-casein was found to induce a significant region-specific upregulation of MOPr
in the brain. This was not seen in the rats receiving the A2 b-casein, indicating that BCM-7 may be at least
partly driving this MOPr upregulation in the motor and somatosensory cortex of the brain. Consistently,
previous work has demonstrated that incubation of peripheral blood mononuclear cells from children
with atopic dermatitis with peptide extracts from cowmilk containing BCM-7 increasedMOPr gene expres-
sion (Fiedorowicz et al., 2014). While it is unclear if the increase in MOPr contributes to the observed immo-
bility phenotype, dysregulation of MOPr function has been implicated in several psychopathologies
including depression, autism spectrum disorder, and schizophrenia (Scarr et al., 2012; Pellissier et al., 2018).
Surprisingly, the direction of MOPr density alterations following exposure to commercial milk containing
A1/A2 b-casein in the somatosensory cortex is opposite of that detected following casein-rich milk expo-
sure, despite both containing A1 b-casein variant. Nonetheless, there are subtle differences in micronu-
trient composition (e.g. fat, protein) of the two milks which may have affected neurochemistry as discussed
above. There was a clear preference for the commercial milk containing A1/A2 b-casein compared to
casein-rich milk with rats consuming on average twice as much A1/A2 milk than casein-rich milk
(161.46 g vs 83.22 g) from PND21 to PND25. As such, differences in the quantity of macronutrients,
including protein, could also be driving this divergent effect on MOPr density in the somatosensory cortex.
This effect is highly unlikely to be driven by milk A1 b-casein as we would have expected an upregulation,
rather than a downregulation ofMOPr in the somatosensory andmotor cortex of casein-rich rats, consistent
with the effect demonstrated in rats consuming commercial milk containing A1/A2 b-casein. It is indeed
plausible that the effect of A1 b-casein on MOPr expression may reflect an agonistic activity of its break-
down peptide BCM7 on the receptor. Regardless of the differential effect of casein-rich and commercial
milk containing A1/A2 b-casein on MOPr density, our findings suggest that intake of milk containing A1
b-casein but not milk containing solely A2 b-casein variant or casein-free milk postweaning negatively
affects immobility behavior and induces brain-specific changes in MOPr density.
From the biochemical analysis of the frontal cortex, a region involved in cognition, decision-making, and
emotional regulation, commercial milk containing A1 b-casein was found to have a substantial impact
on the metabolic landscape of the brain compared to both A2 milk and control groups, which had similar
profiles. This emphasizes the importance of early-life nutritional exposures on neurobiochemistry. Several
choline-related metabolites were altered in response to commercial milk containing A1 b-casein. Lower
amounts of choline and ethanolamine and higher amounts of phosphocholine and acetylcholine were
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observed in the frontal cortex of animals fed commercial milk containing A1 b-casein compared to both
control and A2 b-casein groups. Choline can be synthesized endogenously, but this process is insufficient
to meet the demands of the body. As such, choline is an essential nutrient that is mainly obtained from the
diet. This metabolite is necessary for many functions, including cell membrane structural integrity, cell
signaling, and neurotransmission (Sanders and Zeisel, 2007). Considering these diverse roles, disruptions
in choline metabolism, especially during early life, may have important consequences for brain develop-
ment and function (Zeisel, 2006). Choline is also a major source of methyl donors, important for epigenetic
regulation (Zeisel, 2006). DNA methylation is a key process in the developing brain, with methylation
changes in specific genes linked to depression (Duan and Lu, 2020). During the methylation process, S-ad-
enosylmethionine is converted to S-adenosylhomocysteine as it donates a methyl group to the DNA. In this
study, S-adenosylhomocysteine was present in lower amounts in the commercial milk containing the A1/A2
b-casein group, suggesting hypomethylation in the frontal cortex of these animals. This is in line with a pre-
viously reported decrease in the S-adenosylmethionine/S-adenosylhomocysteine ratio and DNA methyl-
ation states induced by BCM-7 exposure in differentiating neuronal stem cells (Trivedi et al., 2016).
Integrative analysis identified associations between gut microbial derived metabolites in the urine and
several metabolites in the brain which were altered by the type of b-casein variant consumed. This high-
lights the variety of molecules that contribute to the communication between the gut microbiota and
the brain and their potential to bemodified by dietary exposures. For example, trimethylamine, a microbial
metabolite of dietary choline, was negatively correlated with the membrane component phosphocholine
and the neurotransmitter acetylcholine. This suggests that gut microbial activity canmodulate the availabil-
ity of choline with downstream consequences for the abundance of these important neurological mole-
cules. The short-chain fatty acid acetate was also positively associated with formate, S-adenosylhomocys-
teine, and guanosine in the brain and negatively correlated with oxypurinol, phosphocholine, and
acetylcholine. Gut-derived acetate can translocate to the brain and can affect histone acetylation and
thus the epigenetic landscape of the brain, influencing behavior (Mews et al., 2019; Osman et al., 2020).
Decreased urinary excretion of acetate was noted in animals fed A1 b-casein compared to animals who
received A2 b-casein milk. A study in mice corroborates our findings and shows that milk containing only
A2 b-casein results in higher fecal short-chain fatty acids concentrations compared to milk containing a
mixture of A1 and A2 b-casein (Guantario et al., 2020).
The enzyme responsible for the hydrolysis of A1 b-casein to produce BCM-7 is dipeptidyl peptidase-4
(DPP-4). This enzyme is typically found in epithelial and endothelial cells, in a soluble form in the blood,
and also anchored to cell membranes of bacteria present in the gut (Da Silva, 2019). Its activity has been
linked with behavioral disorders in both rats and humans (Canneva et al., 2015; Kamble et al., 2016).
DPP-4 has a spectrum of actions beyond its role as a proteolytic enzyme. It also has a well-established
role in glucose regulation where it regulates the biological activity of the incretin hormone, glucogen-
like peptide-1, helping to maintain normal glucose homeostasis (Deacon, 2019). To this end, A1/A2 milk
consumption resulted in the disruption of several brain metabolites involved in energy homeostasis
including IMP and adenosime monophosphate (AMP), which are breakdown products of ATP, and 3-hy-
droxybutyrate, a ketone body synthesized in the liver and used as an energy source by the brain when
blood glucose is low. Compared to control animals, those fed with commercial milk containing A1/A2
b-casein or A2 milk excreted lower amounts of metabolites involved in the tricarboxylic acid (TCA) cycle
such as citrate and 2-oxoglutarate. This is consistent with findings from Farshim et al. who also reported
lower levels of TCA cycle-related metabolites in the urine of non-weaned animals compared to normally
weaned counterparts (Farshim et al., 2016). Moreover, lower 2-oxoglutarate and citrate levels have previ-
ously been reported in a rat model of depression (Zheng et al., 2011). Together, these findings link b-casein
exposure postweaning to a dysregulation in energy homeostasis.
In conclusion, the data presented here indicate that dietary manipulations around weaning age in the form
of consumption of milk containing both A1/A2 b-casein but not A2 variant alone have important implica-
tions for brain development and emotional behavior via a possible gut-brain axis-mediated mechanism.
It is evident that, intake of milk containing the A1 b casein variant in early postnatal life when both brain
andmicrobiome development are sensitive to environmental factors negatively affects emotional behavior
and induces concomitant brain region-specific neurochemical and metabolic changes alongside alter-
ations to gut-derived metabolic profile. As milk is the major dietary source in infants, the conclusions of
this study emphasize the need to assess the translation relevance of this effect and, if reproduced, inform
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the importance of selecting A1 b casein-free milk and dairy products for consumption during this sensitive
postweaning developmental period.
Limitations of the study
Limitations of this study include differences in the composition of the utilized milks. As mentioned in the
discussion, differences in lipid profiles between the various milks may have had an influence on brain recep-
tor densities. Additionally, milk consumption was recorded per cage and not per animal as individually
housing animals is a stressor, given the social nature of rodents. In future, methods to detect individual an-
imal milk intake should be implemented. Furthermore, the observed altered phenotypes were attributed to
A1 b-casein and ultimately to its breakdown product BCM-7. Nevertheless, BCM-7 was not directly
measured. In the future, collection of blood and fecal content within two hours of milk consumption should
be taken into consideration in order to investigate the presence of BCM-7. Our results suggest that A1
b-casein and BCM-7 play a fundamental role in neurological and behavioral development and provide in-
formation that will inform the development of future more detailed mechanistic studies to investigate this
relationship.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following:




B Data and code availability
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
d METHOD DETAILS
B Forced swim test
B Locomotor test
B Sample collection
B Fluorescence in situ hybridization
B Quantitative OTr and MOPr autoradiography
B
1H nuclear magnetic resonance (NMR) spectroscopy
B
1H NMR data processing and analysis
d QUANTIFICATION AND STATISTICAL ANALYSIS
SUPPLEMENTAL INFORMATION
Supplemental information can be found online at https://doi.org/10.1016/j.isci.2021.103048.
ACKNOWLEDGMENTS
This work was supported by a BBSRC doctoral training grant to A.B. (PI), J.R.S., and I.K: Impact of pro-
longed maternal milk exposure on gut microbiota, brain development, and behavior (grant number BB/
J014451/1) and ‘‘in vivo strategic skills award’’ by the BPS integrative Pharmacology fund, the BBSRC,
and the MRC to A.B. (2013).
AUTHOR CONTRIBUTION
Conceptualization, A.B. and J.S.; methodology, I.K., J.S., and A.B.; software, S.Z.; formal analysis, A.O. and
S.Z.; investigation, A.O., S.Z., G.W., E.F., P.Z., P.G., J.S., and A.B.; resources A.B. and J.S.; data curation,
A.O. and S.Z.; writing – original draft, A.O. and S.Z.; writing – review & editing, A.O., S.Z., G.W., I.K.,
A.B., and J.S.; visualization, S.Z.; supervision, I.K., A.B., and J.S.; project administration, A.B. and J.S.; fund-
ing acquisition, A.B. and J.S.
DECLARATION OF INTERESTS
The a2 Milk Company provided coupons for the purchase of a2 milk used in this study. J.R.S. has received
industry support from Danone Nutricia, Optibiotix Health, AstraZeneca, Servier, and Vitacress and sits on
the ‘‘Gut Microbiota for Health’’ expert panel for the British Society of Gastroenterology. All other authors
declare no competing interests.
ll
OPEN ACCESS




One or more of the authors of this paper self-identifies as an underrepresented ethnic minority in science.
Received: March 30, 2021
Revised: July 13, 2021
Accepted: August 24, 2021
Published: September 24, 2021
REFERENCES
Alm, E.W., Oerther, D.B., Larsen, N., Stahl, D.A.,
and Raskin, L. (1996). The oligonucleotide probe
database. Appl. Environ. Microbiol. 62, 3557.
Altamura, C., Maes, M., Dai, J., and Meltzer, H.Y.
(1995). Plasma concentrations of excitatory amino
acids, serine, glycine, taurine and histidine in
major depression. Eur. Neuropsychopharmacol.
5, 71–75.
Bales, K.L., and Perkeybile, A.M. (2012).
Developmental experiences and the oxytocin
receptor system. Horm. Behav. 313–319.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Male, Wistar albino rats (Charles River UK Limited, Kent) were used in all experiments. Two experimental
groups were generated, the Casein experimental group which was conducted at the University of Surrey
Experimental Animal Unit and the A1/A2 milk experimental group which was conducted at St. George’s
University London Biological Research Facility. For each study, three groups of animals each containing
eight male pups plus their cross-fostered mother were ordered to arrive at PND7, where day of birth is
PND0. These animals were maintained in litters of 8 pups with their mothers at all times. Pups were left
to acclimatize to their new environment for 7 days (until PND14), after which point, they were handled
and weighed daily by the experimenter. All groups were placed in a 12-hour light-dark cycle (lights on
6AM - 6PM) with free access to a standard rat chow diet (B & K Universal Ltd for the casein-rich study
and SDS for the A1/A2 study. See Table S1 for nutritional content of the respective diets). All groups
were kept at a constant temperature of 22C G 1C, humidity of 45-55%. In the Casein study, all groups
were weaned on PND21 and had free access to rat chow and water. The control group was not provided
with any milk post-weaning, the casein-rich group was provided with casein-rich milk (Welpi; Pet Life Inter-
national Ltd, Bury St. Edmunds UK, casein derived from cow’s milk) from PND21 until PND25. Casein-rich
milk was made up by mixing one level scoop of powder (5 g containing 20% w/w casein) with two level
scoops of water (20 g) i.e. 1 part powder to 2 parts water by volume to make 25 mL of liquid Welpi. There
was no supplementation of external source of casein. The casein-free group was provided with milk in
which the casein component was removed and replaced with soy protein (20% w/w of milk powder) (Special
Diet services, Cambridge, UK). Casein-free milk was made up in an identical way as casein-rich milk. For the
casein dose response study, identical casein-free formula utilized in the aforementioned casein study was
spiked with 10% or 20% w/w casein (Sigma, Poole, UK) in milk powder and provided to weaned pups from
PND21. A control group was included which consumed unspiked casein-free milk. Similarly, in the A1/A2
milk study all animals were weaned on PND21 and had free access to rat chow and water. This study con-
sisted of a control group, a group provided with conventional cow’s milk containing a mixture of A1/A2
b-casein (Commercialized whole milk) and a group provided with milk containing exclusively A2 b-casein
(a2 Milk company) from PND21 to PND25. Nutritional content of the various types of milks is reported in




All behavioral tests were carried out between 9 AM and 5 PM. The FST, a two day test, was used to assess
the total time animals spent immobile not attempting to escape from water, a measure which is sensitive to
antidepressant in rats, and it was carried out as originally described by Porsolt et al. (1978). Briefly, animals
were left to acclimatize to the behavioral room, in their home cages, for 1 hrhour prior to testing. On the first
day of testing (PND25), animals were exposed to a 15 min ‘‘pre-test’’ followed 24 hours later by a 6 minutes
‘‘test’’ session. Each rat was individually placed in a glass tank containing tap water maintained at a temp of
23C G 1C (Diameter: 170 nm x Height: 270 cm Fisher Scientific UK). Immediately after each session, the
animals were dried using a paper towel and then placed in a warm (30C G 2C) fanned recovery chamber
for 15 minutes to dry before being returned to home cages. The ‘‘pre-test’’ and ‘‘test’’ sessions were re-
corded using a video camera placed in front of the glass beakers and scored by 3 independent observers
who were blind to the identity of the treatment groups of each animal. The total time spent immobile dur-
ing ‘‘test’’ day on PND26 was quantified from the videos. This was assessed as >2.0 seconds making only
movements necessary to keep head over water. Animals with 0 seconds spent immobile during the test
were excluded from the study and further analysis. All behavioral tests were carried out under low
illuminations levels (40 lux).
Locomotor test
Locomotor activity of each animal in the A1/A2 milk study was assessed for the duration of 20 minutes 1
hour prior the ‘‘pre-test’’ of the FST (PND25). Animals were firstly brought into the locomotor testing
room in their home cages and left to acclimatize 1 hour prior to testing. Animals were then individually
placed in locomotor chambers (40 cm x 20 cm x 20 cm; Linton Instrumentation, Norfolk, UK). Each chamber
consisted of 2 rows of 16 photocells located at right angles to each other projecting horizontal infrared
beams 2.5 cm apart and 6 cm above the cage floor to measure horizontal and vertical activity, respectively.
Activity was recorded as the number of sequential beam breaks in 5-minute bins.
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Animals were individually housed in metabolic cages for 24 hours on PND26 after the FST. Urine samples
gathered from the metabolic cages were collected between 10:00 am and 11:00 am on PND27 and stored
at -80C. On PND27, animals were scarified through cervical dislocation. Intact brains were dissected and
rapidly frozen in isopentane at20 C for 30 seconds and then stored at80 C until quantitative receptor
autoradiography or 1H NMR spectroscopy analysis. The carcasses were transferred into a fume hood and
duodenum, jejunum, ileum, cecum and colon were dissected. Contents from these regions were weighed
(70–200 mg) into sterile 2 ml Eppendorf tubes and kept over ice.
Fluorescence in situ hybridization
Gastrointestinal content from five different gut regions (duodenum, jejunum, ileum, caecum and colon)
were collected in the Casein study and diluted 1:10 (w/v) in PBS (0.1 M, pH 7.0; Oxoid). Tubes were centri-
fuged at 2000 g for 2 minutes and the supernatant collected into a 2 mL Eppendorf tube. This process was
repeated twice, with each supernatant being added to the same 2 mL tube. The resulting supernatant was
centrifuged at 13000 g for 5 minutes and the pellet resuspended in 750 mL of PBS and then fixed with using
4% (w/v) paraformaldehyde solution (2.25 mL, Sigma) for 4 hours at 4C. Following paraformaldehyde fixa-
tion, cells were washed twice in PBS by centrifugation at 13000 g for 5 minutes, resuspended in 600 mL PBS/
ethanol mixture (1:1) and stored at 20 C at least 4 hours prior to hybridization. Intestinal bacterial popu-
lation was assessed by FISH analysis using a collection of 50Cy3-labeled 16S rRNA oligonucleotide probes
(Sigma Aldrich, Dorset, UK). Oligonucleotide probes targeting Bifidobacterium spp. (50-CCAATGTGGGG
GACCTT) Bif164; Clostridium histolyticum group (Clostridium clusters I and II) (50-TTATGCGGTATTAAT
CYCCTTT), Chis150; Lactobacilli/Enterococci spp. (50-GGTATTAGCAYCTGTTTCCA) Lab158 were used
to investigate specific functional group of the gut microbial community (Alm et al., 1996). For total bacterial
cells count, a mixture of different probes (EUB338I/II/III; 50-GCTGCCTCCCGTAGGAGT, 50-GCAGC
CACCCGTAGGTGT and 50-GCTGCCACCCGTAGGTGT) was used. Slides were enumerated using an
EPI-fluorescence Eclipse E400 Nikon microscope (Nikon, U.K., Kingston-upon-Thames, U.K). Fifteen
random microscopic fields of view were counted per assay and used to calculate the number of cells per
gram of original sample.
Quantitative OTr and MOPr autoradiography
Adjacent 20 mm coronal sections from animals of the Casein study and A1/A2 study were cut at 400 mm in-
tervals at 21 C using a cryostat apparatus (Zeiss Microm 505E, Hertfordshire, U.K.) and thaw-mounted
onto gelatin-coated ice-cold microscope slides to define receptor binding levels from fore- to hind-brain
regions. Brain slides were stored at 20 C in airtight containers containing a layer of anhydrous calcium
sulfate (Dreirite-BDH Chemicals, Dorset, U.K.) until used. OTr and MOPr autoradiography were performed
in accordance with previously described methods (Zanos et al., 2014) with minor modifications. Briefly, sec-
tions were rinsed twice for 10 minutes for OTr binding and 20 mins for MOPr binding in a pre-incubation
buffer solution (50 mMTris-HCl, pH 7.4) at room temperature to remove endogenous oxytocin and opioids.
For OTr, the total binding was determined by incubating the sections with 50 pM [125I]-Ornithine vasotocin
analog [d(CH2)5[Tyr(Me)
2,Thr4,Orn8,[125I]Tyr9-NH2]-vasotocin] ([
125I]-OVTA) (Perkin Elmer, Boston, MA) and
for MOPr [3H]-DAMGO (4nM) (Sigma-Aldrich, Poole, UK) in the same incubation buffer medium. For OTr,
adjacent sections were incubated with [125I]-OVTA (50 pM) for 60 minutes in the presence of 50 mM of OTr
ligand, (Thr4, Gly7)-oxytocin (Bachem, Germany), to determine non-specific binding (NSB). For MOPr, NSB
was determined by incubating adjacent sections with 1 mM naloxone for 1 hour. Following the radioligand
binding period, slides were rinsed 3 times for 5 minutes in ice cold rinse buffer (50 mM Tris-HCl, 10 mM
MgCl2, pH 7.4) followed by a 30-minute wash in the ice-cold rinse buffer and a subsequent 2 second
wash in ice-cold distilled water. Slides were then dried under a stream of cool air for 2 hours and stored
in sealed containers with anhydrous calcium sulfate (Drierite BDH Chemicals, Dorset, U.K) for 2 days. Slides
were opposed to Kodak MR-1 films (Sigma-Aldrich, U.K.) in hypercassettes with autoradiographic [14C] mi-
croscales of known radioactive concentration (GE Healthcare Life Sciences, Amersham, U.K.) for 3 days for
the oxytocin binding and with autoradiographic [3H] microscales for 10 weeks for MOPr binding. Films were
developed using 50% Kodak D19 developer (Sigma-Aldrich, Poole, U.K.). Quantitative analysis of autora-
diographic films was carried out using MCID image analyzer (Image Research, Ontario, Canada) as previ-
ously described (Kitchen et al., 1997). Optical density values were quantified from the [14C]-microscale for
OTr analysis and a [3H] microscale for MOPr analysis (GE Healthcare, U.K.) which were entered with corre-
sponding radioactivity values into a calibration table on MCID and the relationship between radioactivity
and optical density was subsequently determined. Analysis of brain structures were carried out by
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reference to the rat brain atlas of Paxinos and Watson (1998). The following structures were analyzed by
sampling 5–8 times with a box tool: cortex (8 3 8 mm), olfactory tubercle (6 3 6 mm) and hippocampus
(5 3 5 mm). While central brain regions such as hypothalamus and thalamus were analyzed by freehand
drawing. Measures were taken from both the right and left hemispheres, thus representing a duplicate
determination for each region. Sections for all treatment groups were processed in parallel and opposed
to the same film at the same time.
1H nuclear magnetic resonance (NMR) spectroscopy
Urines were defrosted and vortexed. Samples were prepared adding 200 mL of phosphate buffer (100%
D2O, 1.5 M KH2PO4, 1 mM TSP and 2 mM sodium azide) to 400 mL of urine. After centrifugation at
13000 g for 10 minutes at 4C, 600 mL of supernatant were transferred into 5 mm NMR tubes.
Brains were defrosted and 80 mg of frontal cortex were weighted into hominization tubes. Ten zirconium
beads and 300 mL of a 2:1 solution of clorophorm/methanol (CHCl3/MeOH) were added to each tube. Vials
were constantly kept on ice until homogenization. A Precellys 24 homogenizer (Bertin Instruments) was
used to run the samples twice at 5500 rpm in a 1 minute program (2x20 sec homogenization with an interval
of 20 sec in between). To each homogenized sample, 300 mL of demineralized water were added and then
centrifuged at 13000 g for 10 minutes at 4C. The aqueous phase was collected in a separate tube while the
organic phase was discarded. The extraction step was repeated twice to collect a total of 600 mL of aqueous
phase. Tubes were left to dry overnight in a vacuum condenser at room temperature. Samples were recon-
stituted with 700 mL of phosphate buffer (100% D2O, 1.5 M KH2PO4, 1 mM TSP and 2 mM sodium azide) on
the day of the experiment, vortexed and centrifugated at 13000 g for 10 minutes at 4C. Finally, 600 mL of
supernatant were transferred into 5 mm NMR tubes.
For both urine and frontal cortex samples, tubes were loaded into a refrigerated (4C) SampleJet robot by
Bruker and standard NOESY (1D NMR) experiments were run in automation at 300 K on a Bruker 600 MHz
UltraShield spectrometer (Bruker Biospin, Karlsruhe, Germany). A standard one-dimensional pulse
sequence with saturation of the water resonance was applied (RD-90-t1-90-tm-90-acquire FID, with RD
set at 2 sec and tm at 100 ms). For each spectrum 8 dummy scans, followed by 64 scans with 32K data points
and a spectral width of 20,000 Hz were acquired.
1H NMR data processing and analysis
Spectra were manually corrected for phase and baseline distortion to the TSP singlet (d 0.00) before data
acquisition on TOPSPIN 3.2 (Bruker, Germany). The obtained spectra were digitized on MATLAB 2017a us-
ing IMPaCTS (https://github.com/csmsoftware/IMPaCTS). Unwanted regions of the spectra were
removed: TSP (-0.2 to 0.2 ppm), water (4.7 to 4.9 ppm) and the urea region (5.48 to 6.23 ppm) in urine sam-
ples. Peaks were manually aligned through recursive sample-wise peak alignment (RSPA) present in
IMPaCTS and normalized to median fold change for urine and to the weight of the sample for brains.
Principal component analysis (PCA) with pareto scaling was used for preliminary unsupervised analysis
and outlier identification. Strong outliers, when present, were removed from further analysis. Peak were an-
notated using in-house database, Chenomx (Chenomx Inc, Edmonton, Canada), HMDB (http://www.
hmdb.ca/) and statistical total correlation spectroscopy (STOCSY) to identify peaks belonging to the
same metabolite. Annotated metabolites and unknown peaks were integrated from the spectra to recover
the highest possible number of metabolites to be used in the downstream analysis.
QUANTIFICATION AND STATISTICAL ANALYSIS
All statistical analyses were performed on R version 4.0.2 (R Foundation for Statistical Computing, Vienna,
Austria). ANOVA, followed by Tukey HSD pos-hoc test, was used to compare the mean immobility time be-
tween groups in the different studies and to evaluate differences in MOPr and OTr binding for the brain
autoradiography experiments. When ANOVA assumptions were not met, Kruskal-Wallis, followed by pair-
wise Wilcoxon tests and Benjamini-Hochberg (BH) correction, was used. When ANOVA resulted significant
both significant (p < 0.05) and close to significant (p < 0.01) pairwise comparisons resulted from Tukey HSD
pos-hoc test were reported. Wilcoxon test, followed by BH correction, was used to compare the mean of
log10 counts in the FISH obtained data, reported significance for p < 0.05. The ‘ropls‘ and ‘mixOmics‘ pack-
ages were used to generate the PCA and PLS-DA models of the integrated metabolites, which were pre-
viously log10 transformed. The ‘ropls‘ package was used to evaluate the significance of the PLS-DA models
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using a 7-fold cross validation and 999 permutations. Metabolites with variable importance projection (VIP)
> 1 were considered relevant for the models and retained in the loading plots of the PLS-DA models. The
metabolic correlation network was generated calculating Spearman correlation between metabolites and
immobility time using the ‘Hmisc‘ package. P values were corrected for false discovering rate (BH) and only
correlations with p adjusted < 0.05 were kept and visualized in the network. The final network was gener-
ated using package ‘igraph‘ and then exported to Cytoscape 3.8.2 for further refinement. Urine and brain
metabolic profiles from the A1/A2 study were integrated using the DIABLO function from the ‘mixOmics‘
package. First, the correlation between the two omics-blocks was calculated using the PLS function in
‘mixOmics‘. The obtained correlation value was then used in the DIABLO design matrix to select highly
correlated and discriminatory variables. Circos plot was generated utilizing only the first component of
the obtained model and displaying highly correlated pairs (r > 0.7).
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